Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

<p>Abstract</p> <p>Background</p> <p>The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and d...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Roeder Falk, Timke Carmen, Saleh-Ebrahimi Ladan, Schneider Lutz, Hackert Thilo, Hartwig Werner, Kopp-Schneider Annette, Hensley Frank W, Buechler Markus W, Debus Juergen, Huber Peter E, Werner Jens
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2012-03-01
Seri Bilgileri:	BMC Cancer
Online Erişim:	http://www.biomedcentral.com/1471-2407/12/112
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!